Anew Medical, Inc.
WENA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|
| Valuation | |||
| PEG Ratio | 0.63 | -0.37 | 0.00 |
| FCF Yield | -2.16% | -0.69% | -0.37% |
| EV / EBITDA | -45.95 | -156.97 | -69.71 |
| Quality | |||
| ROIC | -5.00% | -0.44% | -108.06% |
| Gross Margin | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -0.94 | -0.40 | 0.26 |
| Growth | |||
| Revenue 3-Year CAGR | – | -100.00% | -100.00% |
| Free Cash Flow Growth | -104.16% | -117.75% | 0.00% |
| Safety | |||
| Net Debt / EBITDA | -1.10 | -1.75 | 0.27 |
| Interest Coverage | 0.00 | -26.96 | 0.00 |
| Efficiency | |||
| Inventory Turnover | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 |